Tranexamic Acid
Cyklokapron
Antifibrinolytic Agent
NADAC/unit
$0.3481
No Shortage
Tier 1: 20.1%
23 Manufacturers
25 ANDAs
vs. brand Cyklokapron: Generic saves up to 97% per unit
Market Intelligence
2023-06-21 Class III Recall: Amring Pharmaceuticals Inc
2023-06-21 Class III Recall: AVKARE LLC
Generic Manufacturers
ACTAVIS LABORATORIES FL INCAMERICAN REGENT INCAMNEAL EU LTDAMNEAL PHARMACEUTICALS CO GMBHAMRING PHARMACEUTICALS INCANI PHARMACEUTICALS INCAPOTEX INCAPPCO PHARMA LLCAUROBINDO PHARMA USA INCAVET LIFESCIENCES LTDBIONPHARMA INCCAPLIN STERILES LTDEPIC PHARMA LLCEUGIA PHARMA SPECIALITIES LTDEXELA PHARMA SCIENCES LLCFRESENIUS KABI USA LLCGLAND PHARMA LTDHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCI 3 PHARMACEUTICALS LLCMICRO LABS LTDMILLA PHARMACEUTICALS INCMYLAN INSTITUTIONAL LLCNEXUS PHARMACEUTICALS LLCPFIZER INCRUBICON RESEARCH LTDXGEN PHARMACEUTICALS DJB INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.